10% discount using “MY10” code for order above $499 + Free Shipping
Price range: $96.00 through $275.00
Brand name – Valcivir 1000mg tablets
Generic name – Valacyclovir 1000mg
Manufacturer – Cipla Ltd
Packaging – 3 Tablets in 1 Strip
Delivery Time – 6 To 15 Days.
Valcivir 1000mg is a prescription oral antiviral tablet that contains Valacyclovir Hydrochloride as its active ingredient. Cipla Ltd., one of India’s most respected and globally recognized pharmaceutical companies, manufactures this medicine. Valacyclovir belongs to a class of drugs called antiviral agents. It works by stopping the herpes virus from replicating inside the body. As a result, it reduces the severity and duration of viral infections and helps the body clear the infection more effectively.
Valacyclovir is a prodrug of Acyclovir. This means the body converts it into Acyclovir after absorption. However, Valacyclovir is significantly better absorbed from the gut than Acyclovir itself. After oral intake, Valacyclovir achieves blood concentrations of Acyclovir that are three to five times higher than the same dose of oral Acyclovir alone. This superior bioavailability means patients can take fewer tablets per day while still achieving the same or better therapeutic effect. This makes Valcivir 1000mg a more convenient and clinically effective option than older Acyclovir-based treatments.
Doctors prescribe Valcivir 1000mg for several viral infections caused by the herpes virus family. These include herpes zoster, commonly known as shingles, which is a painful skin rash caused by the reactivation of the varicella-zoster virus. Doctors also use it to treat episodes of genital herpes caused by herpes simplex virus type 2, as well as labial herpes, commonly known as cold sores, caused by herpes simplex virus type 1. Additionally, doctors prescribe it to suppress recurrent genital herpes outbreaks and to reduce the risk of transmitting genital herpes to uninfected partners.
Cipla Ltd. produces Valcivir 1000mg in GMP-certified manufacturing facilities under strict international quality control standards. Cipla has a long and well-established track record in producing high-quality, affordable medicines across multiple therapeutic areas. Because Valacyclovir is one of the most extensively studied antiviral compounds in clinical medicine, doctors prescribe Valcivir 1000mg with complete confidence in its mechanism, safety profile, and clinical effectiveness. Both patients and healthcare professionals rely on this brand for consistent and dependable antiviral results.
To understand how Valcivir 1000mg works, it helps to first understand how herpes viruses behave inside the body. Herpes viruses from the herpesviridae family, including herpes simplex virus type 1, herpes simplex virus type 2, and the varicella-zoster virus, share a common behavioral pattern. After the initial infection, these viruses travel to nerve cells and establish a dormant state called latency. They remain inactive in nerve ganglia for months or years. When the immune system weakens due to stress, illness, or other triggers, the virus reactivates and travels back down the nerve to the skin, causing a new outbreak of lesions or rash.
After a patient takes Valcivir 1000mg orally, the gastrointestinal tract absorbs Valacyclovir rapidly and efficiently. Once absorbed, enzymes in the gut wall and liver convert Valacyclovir almost completely into its active form, Acyclovir. This conversion process is rapid and highly efficient. Because Valacyclovir is specifically designed to improve the oral absorption of Acyclovir, the resulting blood levels of Acyclovir are substantially higher than those achieved by taking Acyclovir directly by mouth at the same dose.
Once Acyclovir reaches the infected cells, it must undergo further activation to become therapeutically active. Inside virus-infected cells, a viral enzyme called thymidine kinase converts Acyclovir into Acyclovir monophosphate. Human cellular enzymes then convert this into Acyclovir triphosphate, which is the fully active form of the drug. Acyclovir triphosphate works by blocking a viral enzyme called DNA polymerase. This enzyme is essential for the herpes virus to copy its genetic material and produce new viral particles. By blocking DNA polymerase, Acyclovir triphosphate stops the virus from replicating. Without replication, the viral population cannot grow, the infection cannot spread to new cells, and the body’s immune system can bring the outbreak under control.
One of the most important safety features of Valacyclovir is its selective activity. Because the first activation step requires the viral thymidine kinase enzyme, Acyclovir becomes highly active only inside herpes virus-infected cells. Healthy, uninfected human cells contain very little thymidine kinase activity of the type needed to activate Acyclovir. As a result, the medicine has minimal toxic effects on healthy body cells. This selective mechanism makes Valcivir 1000mg significantly safer than older antiviral drugs that affect both infected and healthy cells indiscriminately.
Valcivir 1000mg works most effectively when treatment starts as early as possible after the onset of symptoms. This is because the medicine stops viral replication but cannot reverse cell damage that has already occurred. Starting treatment within 24 to 48 hours of the first signs of an outbreak, such as tingling, burning, or early blistering, significantly reduces the severity, duration, and pain associated with the episode. Early treatment also reduces the total viral load more effectively, which may reduce the risk of virus spreading to other people.
For the treatment of shingles in adults, the standard recommended dose of Valcivir is 1000mg taken three times daily for seven consecutive days. Doctors strongly recommend starting treatment within 72 hours of the onset of the shingles rash for the best possible outcome. Starting treatment early significantly reduces the severity of the acute rash, shortens the duration of blistering, and reduces the risk of a painful complication called postherpetic neuralgia, which is persistent nerve pain that can last for months after the rash heals.
For the treatment of an initial episode of genital herpes, doctors prescribe Valcivir 1000mg twice daily for ten days. For recurrent episodes, the standard dose is 500mg twice daily for three days or 1000mg once daily for five days, depending on the doctor’s clinical assessment. Starting treatment at the very first sign of a recurrent episode, such as tingling or itching in the affected area, produces the best results and may prevent the full outbreak from developing.
For the treatment of cold sores caused by herpes simplex virus type 1, doctors prescribe Valcivir 2000mg taken twice daily for one day only. The two doses should be taken approximately 12 hours apart. Treatment must start at the very first sign of a cold sore, ideally when the patient notices the initial tingling, itching, or burning sensation before any visible blister appears. Starting at this earliest prodromal stage produces significantly better results than waiting until the blister is fully formed.
For patients who experience frequent recurrent genital herpes outbreaks, doctors may prescribe long-term suppressive therapy. The standard suppressive dose is 500mg to 1000mg taken once daily on an ongoing basis. This approach significantly reduces the frequency of outbreaks and lowers the risk of viral shedding between episodes. Doctors review the need for continued suppression periodically, typically after twelve months of continuous therapy.
Swallow the tablet whole with a full glass of water. Valcivir 1000mg can be taken with or without food. Food does not significantly affect the absorption or effectiveness of Valacyclovir. However, patients who experience mild stomach discomfort when taking medicines on an empty stomach may prefer taking it with a light meal. Patients must stay well hydrated throughout treatment. Drinking adequate amounts of water throughout the day helps the kidneys process Acyclovir efficiently and reduces the risk of kidney-related side effects, particularly at higher doses.
Patients with kidney impairment require carefully adjusted doses because Acyclovir is primarily eliminated through the kidneys. Reduced kidney function slows this elimination, which can cause Acyclovir to accumulate to levels that harm the kidneys and nervous system. Doctors calculate the appropriate reduced dose and extended dosing interval based on the patient’s estimated kidney function, measured by creatinine clearance. Elderly patients also need careful assessment, as kidney function naturally declines with age. Always inform the doctor about kidney health and all current medicines before starting Valcivir 1000mg.
Most patients tolerate Valcivir 1000mg well when they take it as directed and at the prescribed dose. Common side effects are generally mild and temporary. These include headache, which is the most frequently reported complaint, nausea, stomach pain or mild abdominal discomfort, vomiting, and dizziness. Some patients also experience fatigue or a general feeling of weakness during the treatment course. These effects typically resolve on their own without requiring any specific treatment.
Some patients experience mild skin rash, mild confusion, or mild mood changes during treatment. A small number of patients also develop elevated liver enzyme levels, which is generally mild and reversible. These effects are more likely at higher doses and in patients with kidney impairment. Patients should report any new or persistent symptoms to their doctor for proper evaluation, particularly if they develop any confusion, agitation, or changes in thinking, as these may suggest neurological effects that require prompt medical attention.
Because Acyclovir is primarily eliminated through the kidneys, it can crystallize in kidney tubules if the patient is dehydrated or if the dose is too high relative to kidney function. This crystallization can cause kidney discomfort and, in severe cases, acute kidney injury. Patients must maintain good hydration throughout treatment. Drinking at least eight glasses of water per day during the treatment course significantly reduces this risk. Patients with pre-existing kidney disease need particularly close monitoring.
Although rare, certain serious side effects require urgent medical care. Patients must contact a doctor immediately if they experience any of the following:
Valacyclovir interacts with certain medicines that affect kidney function. Specifically, medicines such as nephrotoxic drugs including aminoglycoside antibiotics, cyclosporine, and tacrolimus can increase the risk of kidney damage when combined with Valacyclovir. Additionally, Probenecid and Cimetidine reduce the kidney’s ability to eliminate Acyclovir, which can cause it to accumulate to higher levels. Patients must always inform their doctor and pharmacist about every medicine they currently take before starting Valcivir 1000mg.
Valcivir 1000mg treats viral infections caused by the herpes virus family. These include shingles caused by the varicella-zoster virus, genital herpes caused by herpes simplex virus type 2, and cold sores caused by herpes simplex virus type 1. Doctors also use it as long-term suppressive therapy to reduce the frequency of recurrent genital herpes outbreaks and to lower the risk of transmitting the virus to uninfected partners.
Valacyclovir is a prodrug that the body converts into Acyclovir after oral absorption. The key clinical advantage is that Valacyclovir achieves blood concentrations of Acyclovir three to five times higher than the same dose of oral Acyclovir. This superior absorption means patients can take fewer daily doses while achieving equivalent or better antiviral effects. Valacyclovir therefore offers greater convenience and improved compliance compared to older Acyclovir tablet regimens.
Valcivir 1000mg begins working as soon as Acyclovir reaches adequate blood concentrations, which typically occurs within one to two hours of taking the tablet. Patients who start treatment at the very first sign of an outbreak generally notice a significant reduction in symptom severity within the first 24 to 48 hours. The total duration of the outbreak shortens meaningfully compared to no treatment. Starting treatment early consistently produces the best clinical outcomes.
No, Valcivir 1000mg does not cure herpes infections. The herpes virus establishes a permanent latent state in nerve cells that current antiviral medicines cannot eliminate. Valcivir 1000mg controls active outbreaks by stopping viral replication. It reduces the severity and duration of symptoms and lowers viral shedding. However, the virus remains dormant in the body and can reactivate in the future. Long-term suppressive therapy reduces but does not completely eliminate the risk of reactivation.
Pregnant women must consult their doctor before taking Valcivir 1000mg. Treating herpes infections during pregnancy is sometimes necessary, particularly for primary genital herpes infections near delivery, as the virus can be transmitted to the newborn during childbirth. Acyclovir, the active metabolite of Valacyclovir, has been used during pregnancy without evidence of fetal harm in clinical studies. However, the doctor must carefully assess the risks and benefits in each individual case before prescribing this medicine during pregnancy.
Staying well hydrated throughout the treatment course is very important. Acyclovir, the active metabolite of Valacyclovir, is eliminated through the kidneys. Adequate fluid intake prevents Acyclovir from crystallizing in kidney tubules. This crystallization can cause kidney discomfort and, in severe cases, kidney injury. Patients must drink plenty of water throughout each day of treatment. This precaution is especially important in elderly patients, patients with pre-existing kidney conditions, and patients receiving high doses.
Yes. When used as daily suppressive therapy, Valacyclovir significantly reduces the risk of transmitting genital herpes to an uninfected sexual partner. Clinical studies demonstrate that daily suppressive therapy with 500mg reduces the risk of transmission by approximately 50% in heterosexual couples where one partner has genital herpes. Using suppressive therapy alongside condoms and avoiding sexual contact during active outbreaks provides the best available protection against transmission. Patients must discuss this approach with their doctor to determine whether it is appropriate for their situation.
Elderly patients can generally use Valcivir 1000mg under medical supervision. However, kidney function declines naturally with age, and since Acyclovir is primarily eliminated through the kidneys, elderly patients are at higher risk of Acyclovir accumulation. Doctors assess kidney function carefully before prescribing Valcivir 1000mg to elderly patients and may reduce the dose or extend the dosing interval accordingly. Elderly patients must also maintain good hydration throughout treatment and report any confusion, dizziness, or changes in urination to their doctor promptly.
If a patient misses a dose, they should take it as soon as they remember. However, if the next scheduled dose is very close, they should skip the missed dose and continue with the regular schedule. Never take two doses together to compensate for a missed one. Doubling the dose increases the risk of side effects, particularly kidney-related effects, without improving the antiviral outcome. Consistent dosing throughout the prescribed course is important for achieving the best treatment results.
Patients with a known allergy to Valacyclovir or Acyclovir must not take this medicine. Patients with severe kidney impairment must use it only under extremely close medical supervision with an appropriately reduced dose. Patients with a history of thrombotic thrombocytopenic purpura or hemolytic uremic syndrome related to antiviral therapy must also avoid Valacyclovir. Additionally, patients currently taking nephrotoxic medicines must discuss the combination carefully with their doctor before starting Valcivir 1000mg.
The most significant clinical advantage of Valcivir 1000mg over older Acyclovir tablets is its dramatically superior oral bioavailability. Because the body converts Valacyclovir into Acyclovir with high efficiency after absorption, blood concentrations of Acyclovir reach three to five times higher levels than the same amount of oral Acyclovir. This means patients achieve a stronger antiviral effect with fewer daily tablets. Instead of the five-times-daily dosing required for oral Acyclovir in some conditions, Valcivir 1000mg achieves equivalent or better results with just two or three doses per day. This simplicity directly improves treatment adherence and patient comfort.
Shingles is one of the most painful conditions in common clinical practice. The combination of acute rash, nerve inflammation, and the risk of lasting postherpetic neuralgia makes timely and effective antiviral treatment essential. Valcivir 1000mg, when started within 72 hours of rash onset, significantly reduces the severity of the acute shingles episode and lowers the risk of developing the persistent nerve pain that follows. For patients who face this distressing condition, choosing a highly bioavailable antiviral like Valcivir 1000mg makes a clinically meaningful difference to their recovery experience.
Valcivir 1000mg addresses two distinct and important clinical goals in genital herpes management. First, it treats individual episodes rapidly and effectively when taken at the first sign of an outbreak. Second, when used as continuous daily suppressive therapy, it significantly reduces the frequency of future outbreaks and lowers the risk of transmitting the virus to an uninfected partner. This dual role makes Valcivir 1000mg uniquely valuable for patients who want both acute episode management and long-term outbreak prevention from a single, trusted medicine.
Valcivir 1000mg works selectively inside herpes virus-infected cells. Because activation of Acyclovir depends on a viral enzyme that healthy human cells do not produce in significant amounts, the medicine exerts its antiviral action precisely where it is needed and causes minimal disruption to healthy tissues. This selective mechanism is one of the key reasons why Valacyclovir has maintained an excellent safety record across decades of widespread clinical use. Patients can take it with confidence knowing that the medicine targets the virus rather than their own healthy cells.
Valcivir 1000mg is not limited to a single type of herpes infection. It works against herpes simplex virus type 1, herpes simplex virus type 2, and the varicella-zoster virus. This broad spectrum within the herpes virus family means that a single medicine can manage multiple clinical presentations, from cold sores to genital herpes to shingles. Doctors therefore rely on Valacyclovir as a versatile and dependable antiviral tool across a wide range of patient presentations and clinical scenarios.
Valcivir 1000mg gives patients and doctors a medicine that delivers its strongest benefits when used earliest in the disease course. Starting treatment at the first prodromal symptom, whether tingling, itching, burning, or early redness, stops the virus before it causes extensive cell damage and before large numbers of infectious viral particles are produced. This early intervention approach consistently produces faster healing, less severe symptoms, shorter outbreak duration, and lower risk of complications such as postherpetic neuralgia. Valcivir 1000mg therefore rewards patients who act quickly at the first sign of an outbreak.
Cipla Ltd. operates across more than 80 countries and consistently ranks among the world’s most trusted and respected pharmaceutical companies. Every Valcivir 1000mg tablet comes from a GMP-certified facility that applies rigorous quality testing at every stage of production. Cipla’s long history of delivering affordable, high-quality medicines makes Valcivir 1000mg a trusted choice for both patients and prescribing doctors. Patients can be fully confident that each tablet delivers a precise, consistent, and clinically effective dose of Valacyclovir every time they take it.
Valacyclovir has been used extensively in clinical medicine since its introduction in the mid-1990s. Decades of post-marketing surveillance, large-scale clinical trials, and real-world use across millions of patients worldwide have generated an extensive body of evidence confirming its safety and effectiveness across diverse patient populations. This long track record gives doctors complete confidence when prescribing Valcivir 1000mg for both short-term treatment and long-term suppressive therapy. Patients can therefore begin treatment knowing that the medicine backing their recovery is one of the most thoroughly studied antivirals in modern medicine.
Disclaimer: This content serves informational purposes only and does not replace professional medical advice. Always consult a licensed healthcare professional before starting, stopping, or adjusting any prescribed medication.
Anti Viral
Anti Viral
Anti Viral
Anti ViralExplore Medicines
Select Using Category
